Novartis stock rose slightly early Tuesday on strong third-quarter income, but the company's biggest moneymaker, Kisqali, fell short. The post Novartis Hikes Income Forecast, But There Were Caveats Within Its Report appeared first on Investor's Business Daily.
CryptoAlerta — análise de criptomoedas e mercado em tempo real